Abstract
In this chapter, we discuss the pathophysiology of the various chronic cardiorenal interactions and their consequences on the sympathetic nervous system (SNS). Increased activity of SNS is observed in all stages of chronic renal disease. The chronic elevation of SNS activity is a major contributor of the complex pathophysiology of hypertension, heart failure, insulin resistance, sleep disorders, diuretic resistance, and progressive kidney disease. Overactivity of SNS contributes to the high incidence of cardiovascular events and cardiac mortality, especially in patients with end-stage renal failure. The dysfunction of sympathetic innervation can be visualized directly by use of [123I]-metaiodobenzylguanidine ([123I]-MIBG) scintigraphy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- [123I]-MIBG:
-
[123I]-Metaiodobenzylguanidine
- CKD:
-
Chronic kidney disease
- CRS:
-
Cardiorenal syndromes
- CSNS:
-
Cardiac sympathetic nervous system
- CV:
-
Cardiovascular
- ESRD:
-
End-stage renal disease
- GFR:
-
Glomerular filtration rate
- H/M:
-
Heart to mediastinum ratio
- HF:
-
Heart failure
- HRV:
-
Heart rate variability
- IDH:
-
Intradialytic hypotension and dialytic hypotension
- MBF:
-
Myocardial blood flow
- NE:
-
Norepinephrine
- NET:
-
Norepinephrine transporter protein
- RAS:
-
Renin-angiotensin system
- RRT:
-
Renal replacement therapy
- RWMA:
-
Regional wall motion abnormality
- SCD:
-
Sudden cardiac death
- WR:
-
Washout rate
References
Adameova A, Abdellatif Y, Dhalla NS (2009) Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease. Can J Physiol Pharmacol 87:493–514
Agostini D, Belin A, Amar MH et al (2000) Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study. J Nucl Med 41:845–851
Agostini D, Verberne HJ, Burchert W et al (2008) I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multi-center study. Eur J Nucl Med Mol Imaging 35:535–546
Ahmed H, Neuzil P, Skoda J et al (2012) Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension. JACC Cardiovasc Interv 5:758–765
Arbab AS, Koizumi K, Araki T (1996) Uptake and washout of I-123-MIBG in neuronal and non-neuronal sites in rat hearts: relationship to renal clearance. Ann Nucl Med 10:211–217
Assa S, Hummel YM, Voors AA et al (2012a) Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and treatment-related factors, and prognostic significance. Clin J Am Soc Nephrol 7:1615–1623
Axelrod S, Lishner M, Oz O, Bernheim J, Ravid M (1987) Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron 45:202–206
Blake GM, Lewington VJ, Zivanovic MA, Ackery DM (1989) Glomerular filtration rate and the kinetics of 123I-metaiodobenzylguanidine. Eur J Nucl Med 15:618–623
Blankenstijn PJ (2004) Sympathetic activity in chronic renal disease. Nephrol Dial Transplant 19:1354–1357
Blankenstijn PJ, London G, Fliser D et al (2011) Major pathways of the reno-cardiovascular link: the sympathetic and renin-angiotensin system. Kidney Int Suppl 1:13–16
Bleyer AJ, Hartman J, Brannon PC et al (2006) Characteristics of sudden death in hemodialysis patients. Kidney Int 69:2268–2273
Boogers MJ, Borleffs JW, Henneman MM et al (2010) Cardiac sympathetic denervation assessed with 123-Iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 55:2769–2777
Boogers MJ, Fukushima K, Bengel FM, Bax JJ (2011) The role of nuclear imaging in the failing heart: myocardial blood flow, sympathetic innervations, and future applications. Heart Fail Rev 16:411–423
Burton JO, Korsheed S, Grundy BJ, McIntyre CW (2008) Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias. Ren Fail 30:701–709
Burton JO, Jefferies HJ, Selby NM, McIntyre CW (2009) Hemodialysis induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4:914–920
Caglar M, Mahmoudian B, Aytemir K et al (2006) Value of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) gated SPECT for the detection of silent myocardial ischemia in hemodialysis patients: clinical variables associated with abnormal test results. Nucl Med Commun 27:61–69
Caldwell JH, Kroll K, Li Z, Seymour K, Link JM, Krohn KA (1998) Quantitation of presynaptic cardiac sympathetic function with carbon-11-meta-hydroxyephedrine. J Nucl Med 39:1327–1334
Caldwell JH, Link JM, Levy WC, Poole JE, Stratton JR (2008) Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med 49:234–241
Campese VM (1997) Neurogenic factors and hypertension in chronic renal failure. J Nephrol 10:184–187
Carrió I (2001) Cardiac neurotransmission imaging. J Nucl Med 42:1062–1076
Chan CT, Hanly P, Gabor J, Picton P, Pierratos A, Floras JS (2004) Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 65:661–665
Chrapko BE, Bednarek-Skublewska A, Staśkiewicz G, Ksiażek A (2012) Relationship of haemodialysis therapy duration and cardiac adrenergic system function assessed by iodine-123 metaiodobenzylguanidine imaging in haemodialysed nondiabetic patients. Nucl Med Commun 33:155–163
Converse RL, Jacobsen TN, Toto RD, Jost CMT, Cosentino F, Fouad-Tarazi F, Victor RG (1992) Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327:1912–1918
Dasselaar JJ, Slart RHJA, Knip M et al (2009) Hemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant 24:604–610
Daugirdas JT (2001) Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 38:S11–S17
DiBona GF (2000) Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 36:1083–1088
DiBona GF (2001) Peripheral and central interactions between the renin-angiotensin system and the renal sympathetic nerves in control of renal function. Ann N Y Acad Sci 940:395–406
Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442
Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW (2000) The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35:681–689
Enzmann G, Bianco F, Paolini F, Panzetta G (1995) Autonomic nervous function and blood volume monitoring during hemodialysis. Int J Artif Organs 18:504–508
Estorch M, Serra-Grima R, Flotas A et al (2000) Myocardial sympathetic innervations in the athlete’s sinus bradycardia: is there selective inferior myocardial wall denervation? J Nucl Cardiol 7:354–358
Flotas A, Carrio I, Agostini D et al (2010) Proposal for standardization of 123-I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 37:1802–1812
Flythe JE, Kimmel SE, Brunelli SM (2011) Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79:250–257
Fonarow GC, Heywood JT (2006) The confounding issue of comorbid renal insufficiency. Am J Med 119(Suppl 1):S17–S25
Furuhashi T, Moroi M (2007) Importance of renal function on prognostic value of cardiac iodine-123 metaiodobenzylguanidine scintigraphy. Ann Nucl Med 21:57–63
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms and prevention. Lancet 382:339–352
Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS (1995) Congestive heart failure in dialysis patients: prevalence, prognosis and risk factors. Kidney Int 47:884–890
Hausberg M, Kosch M, Harmelink P et al (2002) Sympathetic nerve activity in end-stage renal disease. Circulation 106:1974–1979
Hause AA, Anand I, Bellomo R et al (2010) Definition of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant 25:1416–1420
Henneman MM, Bax JJ, van der Wall EE (2007) Monitoring of therapeutic effect in heart failure patients: a clinical application of 123I-MIBG imaging? Eur Heart J. doi:10.1093/eurheartj/ehl325
Henneman MM, Bengel FM, van der Wall EE, Knuuti J, Bax JJ (2008) Cardiac neuronal imaging: application in the evaluation of cardiac disease. J Nucl Cardiol 15:442–455
Herzog CA (2007) Can we prevent sudden cardiac death in dialysis patients? Clin J Am Soc Nephrol 2:410–412
Heywood TJ, Fonarow GC, Costanzo MR, Mathu VS, Woodside JR, Wynne J (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13:422–430
Hsu H-J, Yen C-H, Hsu K-H et al (2012) Association between cold dialysis and cardiovascular survival in hemodialysis patients. Nephrol Dial Transplant 27:2457–2464
Jacobson AF, Senior R, Cerqueira MD et al (2010) Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study. J Am Coll Cardiol 55:2212–2221
John AS, Tuerff SD, Kerstein MD (2000) Nonocclusive mesenteric infarction in hemodialysis patients. J Am Coll Surg 190:84–88
Kasama S, Toyama T, Hatori T et al (2007) Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol. Eur Heart J 28:989–995
Katholi RE, Whitlow PL, Hageman GR, Woods WT (1984) Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertens 2:349–359
KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease (2013) Kidney Int Suppl 3:136–150
Kersh ES, Kronfield SJ, Unger A, Popper RW, Cantor S, Cohn K (1974) Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 290:650–653
Kim KE, Onesti G, Schwartz AB, Chinitz JL, Swartz C (1972) Hemodynamics of hypertension in chronic end-stage renal disease. Circulation. 46(3):456–464
Kline RC, Swanson DP, Wieland DM et al (1981) Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 22:129–132
Koomans HA, Blankestijn PJ (1995) Blood volume preservation in dialysis: tool and strategies. Nephrol Dial Translant 10:1791–1793
Koomans HA, Blankestijn PJ, Joles JA (2004) Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 15:524–537
Kotanko P (2006) Cause and consequences of sympathetic hyperactivity in chronic kidney disease. Blood Purif 24:95–99
Kurata C, Wakabayashi Y, Shouda S et al (1995) Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure. J Nucl Med 36:2037–2043
Kurata C, Uehara A, Sugi T et al (2000) Cardiac autonomic neuropathy in patients with chronic renal failure on haemodialysis. Nephron 84:312–319
Kurata C, Uehara A, Ishikawa A (2004) Improvement of cardiac sympathetic innervation by renal transplantation. J Nucl Med 45:1114–1120
Laaksonen S, Voipio-Pulkki L, Erkinjuntti M, Asola M, Falack B (2000) Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia? J Intern Med 248:21–26
Levin A, Mendelssohn D (2006) Care and referral of adult patients with reduce kidney function: position paper from the Canadian Society of Nephrology. Vancouver, British Columbia: Canadian Society of Nephrology
Mahfoud F, Böhm M (2010) Interventional renal sympathetic denervation – a new approach for patients with resistant hypertension. Dtsch Med Wochenschr 135:2422–2425
Malpas SC (2010) Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 90:513–557
Martins da Silva MI et al (2013) Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure. Rev Port Cardiol 32:509–516
Matsunari I, Aoki H, Nomura Y et al (2010) Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging 3:595–603
McIntyre CW (2009) Effects of hemodialysis on cardiac function. Kidney Int 76:371–375
McIntyre CW (2011) Hemodynamic effects of peritoneal dialysis. Perit Dial Int 31:S73–S76
McIntyre CW, Burton JO, Selby NM et al (2008) Hemodialysis-induced cardiac dysfunction is associated with an acute reduction of global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3:19–26
McMahon LP (2003) Hemodynamic cardiovascular risk factors in chronic kidney disease: what are the effects of intervention? Semin Dial 16:128–139
Merlet P, Benvenuti C, Moyse D et al (1999) Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 40:917–923
Miyanaga H, Yoneyama S, Kamitani T, Kawasaki S, Takahashi T, Kunishige H (1996) Abnormal myocardial uptake and clearance of 123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction. J Nucl Cardiol 3:508–515
Naik RB, Mathias CJ, Wilson CA, Reid JL, Warren DJ (1981) Cardiovascular and autonomic reflexes in haemodialysis patients. Clin Sci 60:165–170
Nakashima Y, Fouad FM, Nakamoto S, Textor SC, Bravo EL, Tarazi RC (1987) Localization of autonomic nervous system dysfunction in dialysis patients. Am J Nephrol 7:375–381
Noordzij W, Glaudemans AW, van Rheenen RW et al (2012) 123I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis. Eur J Nucl Med Mol Imaging 39:1609–1617
Orofino L, Marcen R, Quereda C et al (1990) Epidemiology of symptomatic hypotension in hemodialysis: is cool dialysate beneficial for all patients? Am J Nephrol 10:177–180
Palmer BF, Henrich WL (2008) Recent advances in the prevention and management of intradialytic hypotension. J Am Soc Nephrol 19:8–11
Parisotto V, Lima EM, Silva JMP, de Sousa MR, Ribeiro AL (2008) Cardiac sympathetic dysautonomia in children with chronic kidney disease. J Nucl Cardiol 15:246–254
Pateinakis P, Papagianni A (2011) Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management. Int J Nephrol. doi:10.4061/2011/938651
Reid IA (1992) Interaction between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 262:E763–E778
Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM et al (2010) Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 31:703–711
Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115–126
Rutkowski B (2006) Highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe. Nephrol Dial Transplant 21:4–10
Sapoznikov D, Backenroth R, Rubinger D (2010) Baroreflex sensitivity and sympatho-vagal balance during intradialytic hypotensive episodes. J Hypertens 28:314–324
Sato M, Horigome I, Chiba S et al (2001) Autonomic insufficiency as a factor contributing to dialysis-induced hypotension. Nephrol Dial Transplant 16:1657–1662
Schreiber MJ Jr (2001a) Clinical dilemmas in dialysis: managing the hypotensive patient. Setting the stage. Am J Kidney Dis 38:S1–S10
Schreiber MJ Jr (2001b) Clinical case-based approach to understanding intradialytic hypotension. Am J Kidney Dis 38:S37–S47
Schrier R (2006) Role of diminished renal function in cardiovascular mortality marker or pathogenetic factor? J Am Coll Cardiol 47:1–8
Scott LA, Kench PL (2004) Cardiac autonomic neuropathy in the diabetic patients: does 123I-MIBG imaging have a role to play in early diagnosis? J Nucl Med Technol 32:66–71
Selby NM, McIntyre CW (2006) A systemic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant 21:1883–1898
Selby NM, McIntyre CW (2011) Peritoneal dialysis is not associated with myocardial stunning. Perit Dial Int 31:27–33
Selby NM, Burton JO, Chesterton LJ, McIntyre CW (2006) Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 1:1216–1225
Sobotka PA, Mahfound F, Schlaich MP, Hoppe UC, Böhm M, Krum H (2011) Sympatho-renal axis in chronic renal disease. Clin Res Cardiol 100:1049–1057
Straver B, de Vries PMJM, ten Voorde BJ, Roggekamp MC, Donker AJM, ter Wee PM (1998) Intradialytic hypotension in relation to pre-existent autonomic dysfunction in hemodialysis patients. Int J Artif Organs 21:794–801
Takeishi Y, Atsumi H, Fujiwara S et al (1997) ACE inhibitor reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 38:1085–1089
van der Sande FM, Kooman JP, Leunissen KM (2000) Intradialytic hypotension – new concepts on an old problem. Nephrol Dial Transplant 15:1746–1748
Van Domburg RT, Hoeks SE, Welten GMJM, Chonchol M, Elhendy A, Poldermans D (2008) Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol 19:158–163
Veltman CE, Boogers MJ, Meinardi JE et al (2012) Reproducibility of planar 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging 39:1599–1608
Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BLF (2008a) Prognostic value of myocardial 123-I metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systemic review. Eur Heart J 29:1147–1159
Verberne HJ, Habraken JBA, van Eck-Smit BLF, Agostini D, Jacobson AF (2008b) Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standarisations and validation. Eur J Nucl Med Mol Imaging 35:547–553
Verberne HJ, Verschure DO, Somsen GA, van Eck-Smit BL, Jacobson AF (2011) Vascular time-activity variation in patients undergoing 123I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake. Eur J Nucl Med Mol Imaging 38:1132–1138
Verschure DO, Somsen GA, van Eck-Smit BLF, Verberne HJ (2012) Renal function in relation to cardiac 123I-MIBG scintigraphy in patients with chronic heart failure. Int J Mol Imaging. doi:10.1155/2012/434790
Vink EE, Blankenstijn PJ (2012) Evidence and consequence of the central role of the kidneys in the pathophysiology of sympathetic hyperactivity. Front Physiol 3:29
Vink EE, de Jager RL, Blankestijn PJ (2013) Sympathetic hyperactivity in chronic kidney disease: pathophysiology and (new) treatment options. Curr Hypertens Rep 1:95–101
Vonesh EF, Snyder JJ, Foley RN, Collins AJ (2006) Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int 103:S3–S11
Yamashina S, Yamazaki J (2007) Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging 34:62–73
Ye S, Ozgur B, Campese VM (1997) Renal afferent impulses, the posterior hypothalamus and hypertension in rats with chronic renal failure. Kidney Int 51:722–727
Zilch O, Vos PF, Oey PL, Cramer MJ, Ligtenberg G, Koomans HA, Blankestijn PJ (2007) Sympathetic hyperactivity is reduced by short daily haemodialysis. J Hypertens 25:1285–1289
Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death- executive summary. Eur Heart J 27:2099–2140
Zuidema MY, Dellsperger KC (2012) Myocardial stunning with hemodialysis: clinical challenges of the cardiorenal patients. Cardiorenal Med 2:25–133
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Chrapko, B.E., Franssen, C.F.M. (2015). Autonomic Imaging: The Cardiorenal Axis. In: Slart, R., Tio, R., Elsinga, P., Schwaiger, M. (eds) Autonomic Innervation of the Heart. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45074-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-662-45074-1_20
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45073-4
Online ISBN: 978-3-662-45074-1
eBook Packages: MedicineMedicine (R0)